Reviw on Nanotechnology in Drug Delivery System

[{“box”:0,”content”:”n[if 992 equals=”Open Access”]n

n

n

n

Open Access

nn

n

n[/if 992]n[if 2704 equals=”Yes”]n

n

Notice

nThis is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.n

n[/if 2704]n

n

Year : 2025 [if 2224 equals=””]30/08/2025 at 10:05 PM[/if 2224] | [if 1553 equals=””] Volume : 12 [else] Volume : 12[/if 1553] | [if 424 equals=”Regular Issue”]Issue : [/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] 03 | Page :

n

n

nn

n

n

n

    By

    n

    [foreach 286]n

    n

    Maya Sharma, Jayesh Kumar, Ranu Sharma, Ankit Paliwal, Dileep Kumar, Hemlata Salvi,

    n t

  • n

    n[/foreach]

    n

n[if 2099 not_equal=”Yes”]n

    [foreach 286] [if 1175 not_equal=””]n t

  1. Associate Professor, Student, Student, Student, Student, Student, Pacific College of Pharmacy, Pacific Academy of Higher Education and Research University, Udaipur, Pacific College of Pharmacy, Pacific Academy of Higher Education and Research University, Udaipur, Pacific College of Pharmacy, Pacific Academy of Higher Education and Research University, Udaipur, Pacific College of Pharmacy, Pacific Academy of Higher Education and Research University, Udaipur, Pacific College of Pharmacy, Pacific Academy of Higher Education and Research University, Udaipur, Pacific College of Pharmacy, Pacific Academy of Higher Education and Research University, Udaipur, Rajasthan, Rajasthan, Rajasthan, Rajasthan, Rajasthan, Rajasthan, India, India, India, India, India, India

    2. n[/if 1175][/foreach]

n[/if 2099][if 2099 equals=”Yes”][/if 2099]n

n

Abstract

n

Edit

n

nNanotechnology has emerged as a revolutionary platform in the field of drug delivery, offering novel strategies for the precise, efficient, and controlled delivery of therapeutic agents. The integration of nanocarriers, such as liposomes, polymeric nanoparticles, dendrimers, micelles, and inorganic nanoparticles, has significantly enhanced drug solubility, stability, bioavailability, and targeted delivery to specific tissues or cells. Targeted drug delivery systems based on nanotechnology minimize off-target effects, reduce systemic toxicity, and improve therapeutic outcomes, especially in the treatment of complex diseases like cancer, neurological disorders, cardiovascular diseases, and infectious diseases. This review highlights the fundamental principles of nanotechnology in drug delivery, discusses various types of nanocarriers and their functionalization strategies, and evaluates their role in achieving site-specific and stimuli-responsive drug release. Furthermore, we examine recent advancements, clinical applications, challenges, and future perspectives in the development of nanotechnology-based targeted drug delivery systems to achieve personalized and precision medicine.nn

n

n

n

Keywords: Nanotechnology, Targeted drug delivery, Nanocarriers, Controlled release, Cancer therapy, Precision medicine, Bioavailability, Stimuli-responsive systems.

n[if 424 equals=”Regular Issue”][This article belongs to Trends in Drug Delivery ]

n

[/if 424][if 424 equals=”Special Issue”][This article belongs to Special Issue under section in Trends in Drug Delivery (tdd)][/if 424][if 424 equals=”Conference”]This article belongs to Conference [/if 424]

n

n

n

How to cite this article:
nMaya Sharma, Jayesh Kumar, Ranu Sharma, Ankit Paliwal, Dileep Kumar, Hemlata Salvi. [if 2584 equals=”][226 wpautop=0 striphtml=1][else]Reviw on Nanotechnology in Drug Delivery System[/if 2584]. Trends in Drug Delivery. 30/08/2025; 12(03):-.

n

How to cite this URL:
nMaya Sharma, Jayesh Kumar, Ranu Sharma, Ankit Paliwal, Dileep Kumar, Hemlata Salvi. [if 2584 equals=”][226 striphtml=1][else]Reviw on Nanotechnology in Drug Delivery System[/if 2584]. Trends in Drug Delivery. 30/08/2025; 12(03):-. Available from: https://journals.stmjournals.com/tdd/article=30/08/2025/view=0

nn

n

n[if 992 equals=”Open Access”]Full Text PDF[/if 992]n

n

n[if 992 not_equal=”Open Access”]n

n

n[/if 992]n

nn

nnn

n[if 379 not_equal=””]nn

Browse Figures

n

n

n[foreach 379]

figures

[/foreach]n

n

n

n[/if 379]

n

n

Edit

n

n

n

References n

n[if 1104 equals=””]n

 

  1. 1.Langer, R. (1998). Drug delivery and targeting. Nature, 392(6679), 5–10.
  2. 2. Allen, T. M., &Cullis, P. R. (2004). Drug delivery systems: Entering the mainstream. Science, 303(5665), 1818–1822.
  3. Whitesides, G. M. (2003). The ‘right’ size in nanobiotechnology. Nature Biotechnology, 21(10), 1161–1165.
  4. 4.Rai, M., et al. (2018). Nanotechnology in medicine: Current status and future prospects. Applied Microbiology and Biotechnology, 102(2), 437–449.
  5. 5.Peer, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751–760.
  6. Tiwari, G., et al. (2012). Drug delivery systems: An updated review. International Journal of Pharmaceutical Investigation, 2(1), 2–11.
  7. Allen, T. M., &Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications. Advanced Drug Delivery Reviews, 65(1), 36–48.
  8. Jain, K., et al. (2010). Dendrimers in drug delivery and targeting: From theory to practice. International Journal of Pharmaceutics, 394(1–2), 122–142
  9.  Soppimath, K. S., et al. (2001). Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release, 70(1–2), 1–20.
  10. Singh, R. P., et al. (2017). Biological applications of silver nanoparticles. International Journal of Nanomedicine, 12, 7899–7906.
  11. Liu, Z., et al. (2008). Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Research, 68(16), 6652–6660.
  12. Bertrand, N., et al. (2014). Mechanisms and barriers in cancer nanomedicine: Addressing challenges, looking for solutions. Chemical Reviews, 114(1), 340–361.
  13. Mura, S., et al. (2013). Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 12(11), 991–1003.
  14. Barenholz, Y. (2012). Doxil®—The first FDA-approved nano-drug: Lessons learned. Journal of Controlled Release, 160(2), 117–134.
  15. Chan, J. M., et al. (2010). Targeted nanoparticles for cardiovascular disease. Nanotoday, 5(5), 231–239.
  16.  Saraiva, C., et al. (2016). Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases. Journal of Controlled Release, 235, 34–47.
  17. Weiss, C., et al. (2020). Toward nanotechnology-enabled approaches against the COVID-19 pandemic. ACS Nano, 14(6), 6383–6406.
  1. Bobo, D., et al. (2016). Nanoparticle-based medicines: A review of FDA-approved materials and clinical trials. Pharmaceutical Research, 33(10), 2373–2387.
  1. Pelaz, B., et al. (2017). Diverse applications of nanomedicine. ACS Nano, 11(3), 2313–2381.
  1. Park, K. (2014). Facing the truth about nanotechnology in drug delivery. ACS Nano, 7(9), 7442–7447.21.Farokhzad, O. C., & Langer, R. (2009). Impact of nanotechnology on drug delivery. ACS Nano, 3(1), 16–20.
  1.  Fadeel, B., et al. (2018). Nanotoxicology and nanosafety: Ethical and regulatory challenges. Advanced Drug Delivery Reviews, 136–137, 110–122.
  1. Ventola, C. L. (2012). The nanomedicine revolution: Part 2: Current and future clinical applications. P&T, 37(10), 582–591.
  1. Wang, A. Z., et al. (2012). Nanoparticle delivery of cancer drugs. Annual Review of Medicine, 63, 185–198.
  1. Zhang, Y., et al. (2021). Artificial intelligence in nanomedicine for precision therapy. Nature Communications, 12(1), 1–14.
  2. Dahlin, A. M., et al. (2020). Nanomedicine and precision medicine: Concepts, promises, and challenges. International Journal of Molecular Sciences, 21(13), 4758.

nn[/if 1104][if 1104 not_equal=””]n

    [foreach 1102]n t

  1. [if 1106 equals=””], [/if 1106][if 1106 not_equal=””],[/if 1106]

    2. n[/foreach]

n[/if 1104]

n

nn[if 1114 equals=”Yes”]n

n[/if 1114]

n

n

[if 424 not_equal=””]Regular Issue[else]Published[/if 424] Subscription Review Article

n

n

n

n

n

Trends in Drug Delivery

n

[if 344 not_equal=””]ISSN: 2394-7268[/if 344]

n

n

n

nn

n

[if 2146 equals=”Yes”][/if 2146][if 2146 not_equal=”Yes”][/if 2146]n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n[if 1748 not_equal=””]

[else]

[/if 1748]n

n[if 1746 equals=”Retracted”]n

n

n

n

[/if 1746]n[if 4734 not_equal=””]

n

n

n

[/if 4734]n

n

Volume 12
[if 424 equals=”Regular Issue”]Issue[/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] 03
Received 20/08/2025
Accepted 28/08/2025
Published 30/08/2025
Retracted
Publication Time 10 Days

n

n

90

nn

n

Login

n
My IP
n

PlumX Metrics

nn

n

n

n[if 1746 equals=”Retracted”]n

[/if 1746]nnn

nnn”}]